Viatrexx-Adipose

Product NDC

73069-024

11-digit product format

730690024

Labeler code

73069

Product ID

73069-024_aa6d1c5c-dd65-40b6-bef4-d027a4a8d5e4

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

epinephrine , artery , metenkefalin , adenosine triphosphate , adenosine cyclic phosphate , centella asiatica , citric acid monohydrate , coenzyme a , colchicum autumnale bulb , fumaric acid , interleukin-10 , levocarnitine , lactic acid , pancrelipase lipase , liver , lymph, sodium diethyl oxalacetate , sodium pyruvate , pituitary gland, quinhydrone , succinic acid , parathyroid gland, vein, yohimbine, ferrous fumarate, mecasermin, potassium aspartate and momordica balsamina whole

Dosage form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS

Labeler

VIATREXX BIO INCORPORATED

Marketing category

UNAPPROVED DRUG OTHER

Marketing start

2019-03-29

Marketing end

0000-00-00

Substance

EPINEPHRINE; BOS TAURUS ARTERY; SUS SCROFA ARTERY; ADENOSINE TRIPHOSPHATE; ADENOSINE CYCLIC PHOSPHATE; CENTELLA ASIATICA; CITRIC ACID MONOHYDRATE; COENZYME A; COLCHICUM AUTUMNALE BULB; FUMARIC ACID; INTERLEUKIN-10; LEVOCARNITINE; LACTIC ACID; PANCRELIPASE LIPASE; BEEF LIVER; PORK LIVER; SUS SCROFA LYMPH; BOS TAURUS LYMPH; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA PITUITARY GLAND; BOS TAURUS PITUITARY GLAND; QUINHYDRONE; SUCCINIC ACID; BOS TAURUS PARATHYROID GLAND; SUS SCROFA PARATHYROID GLAND; BOS TAURUS VEIN; SUS SCROFA VEIN; YOHIMBINE; FERROUS FUMARATE; MECASERMIN; POTASSIUM ASPARTATE; MOMORDICA BALSAMINA WHOLE

Active strength

31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Carnitine [CS],Carnitine Analog [EPC],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record